# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Central Serous Chorioretinopathy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-7 of 7 results.
The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC
Status: Recruiting
Last Changed: Oct 02, 2018
First Received: Oct 02, 2018
Disease(s): Central Serous Chorioretinopathy
Intervention(s): Half-dose photodynamic therapy
Locations: Fabao Xu, Guangzhou, Guangdong, China
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
Status: Not yet recruiting
Last Changed: May 31, 2018
First Received: May 31, 2018
Disease(s): Central Serous Chorioretinopathy
Intervention(s): Brinzolamide Ophthalmic
Locations: Iglicki Oftalmologia, Buenos Aires, Argentina
Tel Aviv Medical Center, Tel Aviv, Israel
PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
Status: Not yet recruiting
Last Changed: Nov 15, 2018
First Received: Feb 12, 2016
Disease(s): Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy
Intervention(s): aflibercept
OCT in Rare Chorioretinal Diseases
Status: Recruiting
Last Changed: May 02, 2019
First Received: May 19, 2014
Disease(s): Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
Locations: Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases
Status: Recruiting
Last Changed: Nov 14, 2018
First Received: Nov 04, 2013
Disease(s): Diabetic Macular Edema, Branch Retinal Vein Occlusion, Chronic Central Serous Retinopathy, Macular Telangiectasia
Intervention(s): Topcon Endpoint Management
Locations: Instituto de Oftalmologia Lavinsky, Porto Alegre, RS, Brazil
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Status: Recruiting
Last Changed: Oct 09, 2019
First Received: Oct 09, 2019
Disease(s): Macula Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion, Epiretinal Membrane, Central Serous Retinopathy With Pit of Optic Disc, Commotio Retinae, Vitritis
Intervention(s): Episcleral Celecoxib
Locations: Stanford Medicine Ophthalmology, Palo Alto, California, United States
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Status: Recruiting
Last Changed: Oct 09, 2019
First Received: Oct 09, 2019
Disease(s): Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion, Epiretinal Membrane, Central Serous Retinopathy With Pit of Optic Disc, Commotio Retinae, Vitritis
Intervention(s): Episcleral Dexamethasone
Locations: Stanford Medicine Ophthalmology, Palo Alto, California, United States